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Abstract
Background: Spinal cord injury (SCI) results in fatal damage and currently has no effective treatment. The pathological
mechanisms of SCI remain unclear. In this study, genome-wide transcriptional profiling of spinal cord samples from
injured rats at different time points after SCI was performed by RNA-Sequencing (RNA-Seq). The transcriptomes were
systematically characterized to identify the critical genes and pathways that are involved in SCI pathology.
Results: RNA-Seq results were obtained from total RNA harvested from the spinal cords of sham control rats and
rats in the acute, subacute, and chronic phases of SCI (1 day, 6 days and 28 days after injury, respectively; n = 3 in
every group). Compared with the sham-control group, the number of differentially expressed genes was 1797 in
the acute phase (1223 upregulated and 574 downregulated), 6590 in the subacute phase (3460 upregulated and
3130 downregulated), and 3499 in the chronic phase (1866 upregulated and 1633 downregulated), with an
adjusted P-value <0.05 by DESeq. Gene ontology (GO) enrichment analysis showed that differentially expressed
genes were most enriched in immune response, MHC protein complex, antigen processing and presentation,
translation-related genes, structural constituent of ribosome, ion gated channel activity, small GTPase mediated
signal transduction and cytokine and/or chemokine activity. Kyoto Encyclopedia of Genes and Genomes (KEGG)
pathway analysis showed that the most enriched pathways included ribosome, antigen processing and presentation,
retrograde endocannabinoid signaling, axon guidance, dopaminergic synapses, glutamatergic synapses, GABAergic
synapses, TNF, HIF-1, Toll-like receptor, NF-kappa B, NOD-like receptor, cAMP, calcium, oxytocin, Rap1, B cell receptor
and chemokine signaling pathway.
Conclusions: This study has not only characterized changes in global gene expression through various stages of SCI
progression in rats, but has also systematically identified the critical genes and signaling pathways in SCI pathology.
These results will expand our understanding of the complex molecular mechanisms involved in SCI and provide a
foundation for future studies of spinal cord tissue damage and repair.
The sequence data from this study have been deposited into Sequence Read Archive (http://www.ncbi.nlm.nih.gov/sra;
accession number PRJNA318311).
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Background
Spinal cord injury (SCI) results in a devastating loss of
motor and sensory functions. In the United States, it has
been reported that some 300,000 people are living with
SCI and nearly 12,000 new patients are diagnosed annu-
ally [1]. In China, the incidence of traumatic SCI is ap-
proximately 60,000 per year [2]. Despite advances in
surgical techniques for the spinal cord, there are still no
effective treatments for this devastating neurological dis-
order. Therefore, it is very important to further under-
stand the molecular changes in SCI in order to develop
a better therapeutic program.
The pathological changes following traumatic SCI can
be divided into two processes: primary injury and sec-
ondary injury. Primary injury is the immediate effect of
mechanical damage on the spinal cord, which directly
damages various tissue components. Secondary injury is
a cascade of effects triggered by the primary injury affect-
ing multiple biological processes and producing extensive
temporal changes in gene expression [3]. Considering the
complexity of gene expression and signaling pathways, a
global analysis is necessary to understand the molecular
mechanisms and develop therapeutic strategies for SCI.
During the last decade, cDNA microarray and genechip
technologies have provided valuable insights into gene
changes after SCI [4–6]. However, these technologies have
suffered from limitations in resolution, dynamic range
and accuracy [7]. With the advances in genome-wide
transcriptome analysis, especially high-throughput RNA
sequencing (RNA-Seq) technology, we now have a
more useful approach to observe whole transcriptome
changes [7, 8].
In this study, temporal genome-wide gene expression
profiles in injured spinal cords of adult rats were examined
using RNA-Seq, and the results were confirmed by real-
time quantitative reverse-transcriptase polymerase chain
reaction (qRT-PCR). Based on these data, the functions
and pathways involved in the pathologic process of SCI in
the acute, subacute, and chronic phases were characterized.
The bioinformatics analysis confirmed that some of the
expressed genes in our study have been shown to play im-
portant roles in SCI, thus supporting the reliability of our
data. We also identified many additional expressed genes
whose functions in SCI have not been well studied. These
additional genes may be involved in the pathological
process of SCI and deserve further study and discussion.
Methods
Animals
We used 12 female Sprague-Dawley rats (eight-week-old,
220–250 g, RRID: RGD_70508) in this study. Animal care
in surgical procedures and after operation were in accord-
ance with Regulations for the Administration of Affairs
Concerning Experimental Animals (Ministry of Science
and Technology, China; revised in June 2004) and Guide-
lines and Policies for Rodent Survival Surgery provided by
the Animal Care and Use Committees of Bengbu Medical
College.
Contusive SCI
To perform the contusive SCI, a New York University
Impactor was used as described [9]. Rats were anesthe-
tized by using pentobarbital (50 mg/kg, intraperitoneal)
and received a T9 vertebral laminectomy. Sham-operated
(sham) rats only received a laminectomy without contu-
sive injury. For making contusive injury, the spine was sta-
bilized by clamping T7 and T11 spinous processes. A
weight drop injury of the cord was made by using a 10 g
rod (2.5 mm diameter) dropped at a height of 25 mm on
the exposed dorsal surface. After injury, animals were
placed in a humidity- and temperature-controlled cham-
ber. In 3 consecutive days, buprenorphine (0.05 mg/kg,
SQ; Reckitt Benckise, Hull, England) was used every 12 h
to relieve pain. Bladder emptying was manually performed
three times daily until autonomous urination was estab-
lished. Chloramphenicol (50 ~ 75 mg/kg) was daily pro-
vided via drinking water to prevent infections.
Basso, Beattie, and Bresnahan (BBB) locomotor rating scale
BBB locomotor rating scale was used to assess the hind-
limb movements based on observation of the rat’s freely
moving in an open field [10, 11]. The evaluations were
performed by 2 scorers while rats were walking freely on
the open-field surface for 4 min. The scores were evalu-
ated before operation, at 1 day, 3, 6, 10, 14, 21, and
28 days after injury.
RNA isolation, quantification, and qualification
Spinal cords (5 mm spinal cord segment containing the
injury epicenter) of sham, acute, subacute, and chronic
phases were harvested at 6 days, 1 day, 6 days, and 28 days
after injury, respectively (n = 3 in every group). Rats were
perfused with phosphate buffer saline (PBS) before remov-
ing the spinal cords. The total RNA from spinal cords was
extracted using TRIzol reagent (Invitrogen, New Jersey,
NJ, USA). Genomic DNA was removed by using DNase I.
The 1% agarose gels were used to monitor RNA degrad-
ation and contamination. NanoPhotometer® spectropho-
tometer (IMPLEN, CA, USA) was used to check RNA
purity. Qubit® RNA Assay Kit in Qubit® 2.0 Flurometer
(Life Technologies, CA, USA) was used to measure RNA
concentration. RNA Nano 6000 Assay Kit of the Bioanaly-
zer 2100 system (Agilent Technologies, CA, USA) was
used to assess RNA integrity.
Library preparation for transcriptome sequencing
For the sample preparations, 3 μg RNA was used as in-
put material for every sample. NEBNext® Ultra™ RNA
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Library Prep Kit for Illumina® (NEB, USA) was used to
generate sequencing libraries. For each sample, the index
codes were added to attribute sequences. The poly-T
oligo-attached magnetic beads were used to purify mRNA
from total RNA. In NEBNext First Strand Synthesis Re-
action Buffer (5×), the mRNA was fragmented by divalent
cations under elevated temperature. M-MuLV Reverse
Transcriptase (RNase H) and random hexamer primers
were used to synthesize the first strand cDNA. RNase H
and DNA polymerase I were subsequently used to
synthesize the second strand cDNA. The exonuclease/
polymerase activities converted remaining overhangs
into blunt ends. To prepare for hybridization, the 3′
ends of DNA fragments were adenylated and ligated to
NEBNext Adaptor with hairpin loop structure. AMPure
XP system (Beckman Coulter, Beverly, USA) was used to
purify the library fragments to select cDNA fragments of
preferentially 150–200 bp. Before PCR, size-selected,
adaptor-ligated cDNAs were treated with 3 μl USER
Enzyme (NEB, USA) at 37 °C for 15 min followed by
95 °C for 5 min. Index (X) Primer, Universal PCR primers
and Phusion High-Fidelity DNA polymerase were used to
perform PCR. Finally, AMPure XP system was used to
purify PCR products, and the Agilent Bioanalyzer 2100
system was used to assess library quality.
Clustering and sequencing
TruSeq PE Cluster Kit v3-cBot-HS (Illumina) was used
to cluster the index-coded samples on a cBot Cluster
Generation System by Novogene (Beijing, China) accord-
ing to the manufacturer’s instructions. Finally, the 125 bp/
150 bp paired-end reads were generated and sequenced
on an Illumina Hiseq platform.
Data analysis
Quality control
To obtain high-quality clean data for downstream ana-
lyses, the low quality reads and reads containing adapters
or ploy-N in raw data were removed and the Q20, Q30
and GC content of those clean data were also calculated.
Reads mapping to the reference genome
From genome website, the files of reference genome and
gene model annotation were downloaded. Bowtie v2.2.3
was used to build the reference genome index. TopHat
v2.0.12 was used to align the paired-end clean reads to
the reference genome.
Gene expression level quantification
The reads numbers mapped to each gene were counted
by HTSeq v0.6.1. Fragments Per Kilobase of transcript
sequence per millions base pairs sequenced (FPKM)
was calculated. FPKM is the most commonly used
method for evaluating the sequencing depth and gene
length of the reads and estimating the levels of gene
expression [12].
Analysis of differential expression
Differential expression of four groups (three biological rep-
licates per group) was analyzed using the DESeq R package
(1.18.0). To control the false discovery rate, Benjamini and
Hochberg’s approach was used to adjust the P-values ob-
tained from DESeq analysis. The adjusted P-value < 0.05
was adopted as the standard for judging statistically signifi-
cant differences in gene expression.
Gene ontology (GO) and Kyoto encyclopedia of genes
and genomes (KEGG) enrichment analysis of differentially
expressed genes (DEGs)
The GOseq R package was used to perform GO enrich-
ment analysis of DEGs. A corrected P-value < 0.05 was
adopted as the standard for judging statistically significant
enrichment of differentially expressed genes. KEGG en-
richment analysis of DEGs was implemented by KOBAS
software.
qRT-PCR
To validate RNA-Seq results, 13 selected DEGs were
verified by qRT-PCR as described [13]. A reverse tran-
scription system (Promega, Madison, WI) was used to
reverse-transcribe the total RNA used in RNA-Seq into
cDNA. SYBR Green PCR Master Mix and the ABI 7900
PCR detection system (Applied Biosystems, Foster City,
CA) were used to perform real-time PCR. To normalize
gene expression, the housekeeping gene glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) was parallel amp-
lified. PCR primer sequences are listed in Table 1. The
ΔΔCt method [14] was used to calculate the relative ex-
pression level of target mRNAs. The relative mRNA ex-
pression value in sham group was designated as 1.
Results
BBB scores at different stages of SCI
To observe the level of impairment produced by SCI,
BBB scores were evaluated. As shown in Fig. 1, all animals
scored 21 points before injury. At 1 day post-SCI, all nine
spinal cord-injured rats received a score of 0, while the
three sham-operated animals still received scores of 21
points. On the 3rd and 6th days, the mean BBB scores of
the six surviving injured rats were 1 ± 0 and 5.33 ± 1.53,
respectively. After 6 days, with only three injured rats
remaining, BBB scores had improved substantially. The
mean scores at 10 days post-injury (dpi), 14 dpi, 21 dpi
and 28 dpi were 8.33 ± 1.53, 9.33 ± 1.53, 10.67 ± 0.58, and
11.67 ± 0.58, respectively. According to our previous ex-
perience, this was a moderate level of impairment.
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Identification of expressed transcripts in the rat spinal
cord transcriptome
In this study, we established 12 cDNA libraries with the
following designations. Libraries with the A designation
were from the sham-operated spinal cords and libraries
B1, B2 and B3 were from injured spinal cords at 1 dpi, 6
dpi and 28 dpi, respectively, which represented of sham
and three different pathological stages of SCI (acute, sub-
acute, and chronic phases). RNA-Seq generated 41,724,966
to 58,619,478 raw reads for each library. After filtering the
low-quality reads, the average number of clean reads was
42,505,205 (87.73%), 43,520,840 (82.37%), 43,336,187
(91.37%), and 42,483,112 (89.70%) for the A, B, C and
D groups, respectively (Table 2). The clean reads were
used for all further analyses, and from them 77.44% to
88.79% of clean tags from the RNA-Seq data mapped
uniquely to the genome, while a small proportion of
them (<3%) were mapped multiple times to the genome
(Table 3).
Identification of the source of variance in the expressed
transcripts by principal component analysis (PCA)
To demonstrate the source of variance in our data, PCA
analysis with three principal components (PC1, 2, and 3)
was performed. As shown in Fig. 2, PC score plots showed
that the contribution of PC1, 2, and 3 was 56.89%, 11.90%,
and 7.77%, respectively. The three individual samples col-
lected at the same time points after injury were clustered
closely together which validated the finding of low vari-
ance in the present analysis study and showed that the
data could be used for the following analysis.
Differential gene expression in spinal cords at different
injury stages
RPKM was used to estimate the level of gene expression,
and DEGSeq was used to examine the differential gene
expression profile. Comparing the SCI and sham animals,
we observed 1,979 DEGs at 1 dpi, with 1,223 upregulated
and 574 downregulated genes (Fig. 3a and Additional
file 1: Table S1), 6590 DEGs at 6 dpi, with 3460 upregulated
and 3130 downregulated genes (Fig. 3b and Additional
file 1: Table S1) and 3499 DEGs at 28 dpi, with 1866
upregulated and 1633 downregulated genes (Fig. 3c and
Additional file 1: Table S1). There were 2950 DEGs be-
tween the 6 dpi and 1 dpi groups, with 1914 upregu-
lated and 1036 downregulated genes (Fig. 3d and
Additional file 1: Table S1). There were 861 DEGs be-
tween the 28 dpi and 1 dpi groups, with 591 upregulated
and 270 downregulated genes (Fig. 3e and Additional
file 1: Table S1). There were 2215 DEGs between the 28
dpi and 6 dpi groups, with 986 upregulated and 1229
downregulated genes (Fig. 3f and Additional file 1:
Table S1). A list of the most relevant genes that were
over-expressed or under-expressed and how their expres-
sion changed with time is shown in Additional file 2:
Table S2.
Table 1 Real-time PCR primers used in the study
Gene GenBank accession no. Forward primer 5′ - 3′ Reverse primer 5′ - 3′
C1qb NM_019262.1 TTCACCTACCACGCCAGTTC GCTTCAAGACTACCCCACCC
Ccl2 NM_031530.1 TGATCCCAATGAGTCGGCTG GGTGCTGAAGTCCTTAGGGT
Cxcl2 NM_053647.1 CAGGGTACAGGGGTTGTTGT AGGTCAGTTAGCCTTGCCTT
Enpp3 NM_019370.2 TGACTCCGGATTTGCCGAAA CTTCGCAGTTGGAACTCCCT
Il6 NM_012589.2 ACCCCAACTTCCAATGCTCT AGCACACTAGGTTTGCCGAG
Pf4 NM_001007729.1 TCCAGGATCCATCTCAAACGC TTTGCTCCCATTCTTCAGCG
Tspo NM_012515.2 GGTGGACCTCATGCTTGTCA CCTCGCCGACCAGAGTTATC
Plau NM_013085.3 GCGGAACTCCTATAACCCCG GTGGCACTCTCTTGTCCGAA
Ncf1 NM_053734.2 CATTGAGGCCGGTGAGATCC AGTTCAAGAGGTGTGGGCAG
Lcn2 NM_130741.1 CAAGTGGCCGACACTGACTA CATTGGTCGGTGGGAACAGA
Fig. 1 BBB scores at different stages of the SCI. The BBB scores were
shown at different stages of the SCI: before injury (n= 12); sham (n= 3);
1 dpi (n = 9); 3 dpi and 6 dpi (n = 6); 10 dpi, 14 dpi, 21 dpi, and 28
dpi (n = 3)
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Confirmation of differential gene expression by qRT-PCR
To verify the expression profiles obtained by RNA-Seq,
ten genes were randomly selected to analyze their tran-
script expression levels by qRT-PCR. The selected genes
included C1qb, Ccl2, Cxcl2, enpp3, IL6, Lcn2, Ncf1, Pf4,
Plau, and Tspo. The results showed that these genes dis-
played similar expression patterns between RNA-seq
and qRT-PCR (Fig. 4).
Hierarchical cluster analysis of gene expression in spinal
cords at different injury stages
Based on the similarity of gene expression patterns,
7632 DEGs were classified into expression cluster groups
by hierarchical clustering (Fig. 5). These clusters con-
tained genes that were up- or downregulated throughout
the whole course of SCI. Based on the expression pat-
terns of these clusters, we can found that some showed
marked differences between different stages of SCI,
while others showed relatively minor differences. For ex-
ample, most of the genes upregulated at 1 dpi (B), 6 dpi
(C) and 28 dpi (D) compared to the sham group (A)
were in the upper cluster, while downregulated genes
were observed in the lower cluster.
K-means clustering of DEGs
To further investigate the biological characteristics of
the 7632 DEGs, K-means clustering was performed. In
the analysis, DEGs were statistically grouped into eight
subclusters based on their expression patterns in spinal
cords at different injury stages. Figure 6 shows the trends
of distinct significantly expressed subclusters of all DEGs.
There were 3082 and 400 genes in subclusters 1 and 6, re-
spectively. The gene expression levels showed a similar
trend in both clusters, which were highest in sham (A),
and lowest in SCI animals at 6 dpi (C). Subclusters 3, 4, 5,
7 and 8 included 482, 1612, 1477, 274 and 62 genes, re-
spectively. The gene expression levels showed a similar
trend in these five subclusters, with lowest expression in
sham (A) and highest expression in SCI animals at 6 dpi
(C). There were 243 genes in subcluster 2, which
expressed at the lowest level in sham (A) and at the high-
est at 1 dpi (C) with a progressive decrease at 6 dpi (C)
and 28 dpi (D). The list of gene IDs in eight subclusters
are shown in Additional file 3: Table S3.
GO enrichment of DEGs
GO enrichment analysis was conducted to characterize
the DEG profiles presented above. GO enrichment results
for all DEGs are provided in Additional file 4: Table S4.
In acute SCI (1 dpi), 35 significant GO terms were
detected in the upregulated genes (Additional file 5:
Figure S1 and Additional file 6: Table S5). No signifi-
cant terms were found in the downregulated genes at 1
dpi (Additional file 7: Figure S2 and Additional file 8:
Table S6).
In subacute SCI (6 dpi), 33 significant GO terms were
detected in the up-regulated genes (Additional file 9:
Figure S3 and Additional file 6: Table S5). Among the
down-regulated genes at 6 dpi, 40 significant GO terms
were detected (Additional file 10: Figure S4 and Additional
file 8: Table S6).
In chronic SCI (28 dpi), 31 significant GO terms were
detected in the up-regulated genes (Additional file 11:
Figure S5 and Additional file 6: Table S5). Among the
down-regulated genes at 28 dpi, 28 significant GO
terms were detected (Additional file 12: Figure S6 and
Additional file 8: Table S6).
Table 2 Summary of sequence assembly after Illumina sequencing
Sample name Raw reads Clean reads clean bases Error rate (%) Q20 (%) Q30 (%) GC content (%)
A1 44881934 40093612 6.01G 0.02 95.33 88.31 50.28
A2 54272034 45508458 6.83G 0.02 97.31 92.22 50.48
A3 46199060 41913544 6.29G 0.02 96.3 90.38 49.91
B1 52270362 44613686 6.69G 0.02 97.09 91.43 50.31
B2 47612764 43741790 6.56G 0.02 96.03 89.63 50.16
B3 58619478 42207044 6.33G 0.02 98.35 93.93 50.37
C1 47746200 44041564 6.61G 0.02 96.17 89.9 50.37
C2 52818270 45368646 6.81G 0.02 97.14 91.56 50.88
C3 41724966 40598352 6.09G 0.03 94.79 87.81 50.96
D1 54673906 45455460 6.82G 0.02 96.48 89.84 50.48
D2 41816080 40410590 6.06G 0.03 94.79 87.89 50.6
D3 45601476 41583286 6.24G 0.02 95.94 89.46 50.51
A1- A3: sham; B1- B3: 1 dpi; C1- C3: 6 dpi; D1- D3: 28 dpi;
Q20: The percentage of bases with a Phred value > 20;
Q30: The percentage of bases with a Phred value > 30
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KEGG enrichment analysis
KEGG enrichment analysis was conducted to identify
pathways that play important roles in the pathologic
process of SCI. KEGG enrichment results of DEGs are
shown in Additional file 13: Tables S7, Additional file 14:
Table S8, and Additional file 15: Table S9.
In acute SCI (1 dpi), ribosome, TNF signaling pathway,
proteoglycans in cancer, malaria, and staphylococcus aur-
eus infection were enriched pathways in all DEGs; Of the
13 enriched pathways in upregulated DEGs, the top ten
were ribosome, TNF signaling pathway, malaria, salmon-
ella infection, leishmaniasis, HIF-1 signaling pathway, pro-
teoglycans in cancer, leukocyte transendothelial migration,
Chagas disease (American trypanosomiasis), and staphylo-
coccus aureus infection; the 2 enriched pathways in down-
regulated DEGs were circadian entrainment and axon
guidance (Additional file 16: Figure S7 and Additional
file 13: Table S7).
In acute SCI (6 dpi), glutamatergic synapse, circadian
entrainment, GABAergic synapse and retrograde endo-
cannabinoid signaling were pathways enriched in all
Fig. 2 PCA analysis of the expressed transcripts. PCA analysis with
three principal components (PC1, 2, and 3) was performed to
demonstrate the source of variance in our data (n = 3)
Fig. 3 Volcano map of differentially expressed genes. Significantly upregulated and downregulated genes are shown as a red and green dot,
respectively. The blue dot represents no significant difference between the expressions of genes. a 1 dpi vs sham, b 6 dpi vs sham, c 28 dpi vs
sham, d 6 dpi vs 1 dpi, e 28 dpi vs 1 dpi, f 28 dpi vs 6 dpi
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DEGs. The top ten pathways of the 27 enriched pathways
in upregulated DEGs were ribosome, osteoclast differ-
entiation, lysosome, NF-kappa B signaling pathway, TNF
signaling pathway, Toll-like receptor signaling pathway,
NOD-like receptor signaling pathway, Chagas disease
(American trypanosomiasis), pertussis and salmonella
infection. The top ten pathways of the 37 pathways
enriched in downregulated DEGs were glutamatergic
synapse, circadian entrainment, GABAergic synapse,
retrograde endocannabinoid signaling, calcium signaling
pathway, dopaminergic synapse, neuroactive ligand-receptor
interaction, adrenergic signaling in cardiomyocytes, insulin
secretion and nicotine addiction (Additional file 17:
Figure S8 and Additional file 14: Table S8).
In chronic SCI (28 dpi), 39 pathways were enriched in
all DEGs; the top ten were ribosome, circadian entrain-
ment, glutamatergic synapse, GABAergic synapse, retro-
grade endocannabinoid signaling, salivary secretion, platelet
activation, cAMP signaling pathway, nicotine addiction and
lysosome; In the 21 pathways enriched in upregulated
DEGs, the top ten were ribosome, lysosome, hematopoietic
cell lineage, staphylococcus aureus infection, osteoclast
differentiation, tuberculosis, leishmaniasis, Fc gamma
R-mediated phagocytosis, phagosome and NF-kappa B
signaling pathway. Of the 25 pathways enriched in
downregulated DEGs, the top ten were circadian en-
trainment, cAMP signaling pathway, glutamatergic syn-
apse, nicotine addiction, calcium signaling pathway,
GABAergic synapse, retrograde endocannabinoid sig-
naling, adrenergic signaling in cardiomyocytes, axon
guidance and neuroactive ligand-receptor interaction
(Additional file 18: Figure S9 and Additional file 15:
Table S9).
Discussion
In this study, we modeled SCI in rats using the New
York University Impactor. According to the BBB scores
and our previous experience [9, 15], our model produced
a moderate level of impairment. To establish a system-
atic global analysis of gene expression patterns in the in-
jured spinal cord, we used RNA-Seq to characterize the
temporal changes after contusive SCI in rats at acute (1
dpi), subacute (6 dpi), and chronic (28 dpi) phase time-
points. The transcriptomes were systematically charac-
terized with the goal of identifying pathways and genes
critical in SCI pathology. Before data analysis, the quality
of the cDNA library was examined. Our results showed
that more than 77% of clean tags from RNA-Seq data
mapped uniquely to the genome and that variance in the
expressed transcripts as analyzed by PCA was low. These
results demonstrated that our data was of sufficient
quality to be used for functional analyses.
Comparing each time point to all other time points,
hundreds to thousands of differentially expressed genes
were obtained in the acute, subacute, and chronic phases
of SCI. Hierarchical cluster analysis and K-means cluster-
ing analysis further indicated that more than 3000 genes
in the two clusters decreased post-SCI and reached the
lowest level at 6 dpi. There were more 4000 genes in five
other clusters showing an increasing trend. Most of these
genes increased post-SCI and reached the highest level at
6 dpi. There were only 243 genes in cluster 2 which
expressed at the highest level at 1 dpi, followed by a
decrease at 6 dpi and 28 dpi. These results suggest that
our analysis may provide new information related to
gene expression profiles for the study of SCI patho-
logical mechanisms.
Fig. 4 Quantitative RT-PCR validations of DEGs characterized by RNA-Seq. The relative expression level of target mRNAs was calculated using
the ΔΔCt method and expressed relative to the value in the sham group (designated as 1). Data represent the mean ± SD (n = 3). Log2 fold
change was the ratio of average Log2 folds between samples
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To further characterize the above DEG profiles, GO
enrichment analysis was performed. The analysis results
showed that for statistically significant differentially
expressed genes, most enrichment occurred in immune
response, MHC protein complex, antigen processing and
presentation, translation-related genes, structural constitu-
ent of ribosome, ion gated channel activity, small GTPase
mediated signal transduction, cytokine and/or chemokine
activity, among others. KEGG pathway analysis showed
that the top enriched pathways included ribosome, antigen
processing and presentation, retrograde endocannabi-
noid signaling, axon guidance, dopaminergic synapses,
glutamatergic synapses and GABAergic synapses, as
well as TNF, HIF-1, NF-kappa B, Toll-like receptor,
NOD-like receptor, cAMP, calcium, oxytocin, Rap1, B
cell receptor and chemokine signaling pathway. In an early
study using a mouse SCI model [16], gene profiling data
at acute (2 days) and subacute phases (7 days after injury)
showed that “inflammation response”, “cell death and
survival”, “nervous system development” and “neurological
disease” were the top enriched functional categories.
“Acute Phase Response Signaling”, “LXR/RXR Activation”,
“Role of Pattern Recognition Receptors in Recognition of
Bacteria and Viruses” and “Atherosclerosis Signaling” were
the most enriched pathways [16]. Comparing our findings
to the mouse gene profiling data, we find that although
animal species and data analysis methods were different,
there were still many similar findings between the rat and
mouse models. For example, “inflammation response” in
the mouse model is similar to “immune response” in the
rat model. “Role of Pattern Recognition Receptors in
Recognition of Bacteria and Viruses” in mice is related
to “Toll-like receptor” and “NOD-like receptor” in rats
[17, 18]. These results demonstrate that there are in-
deed some similarities between the mechanisms of SCI
in rats and mice. However, we also found many more
differences in gene expression and signaling pathways
between these two species. The use of high throughput
RNA-Seq, coupled with different species and different
laboratory results, makes it is difficult to ascertain the
causes of these differences. In fact, the pathology of SCI
in rats and mice is distinct, particularly with regard to
cavity formation and scar/inflammatory responses, and
the rat model is more similar to human SCI [19, 20].
Thus, more thorough mechanistic research using the
rat model may be a better approach for understanding
human SCI.
In addition to differing species, the choice detection
methods may also produce important differences. There
are at least four other groups that have studied gene ex-
pression during acute, subacute, and chronic SCI using
methods different from RNA-Seq [21–24]. In the follow-
ing sections, we will discuss the important similarities
and differences in gene expression patterns in the injured
spinal cord between our RNA-Seq results and data avail-
able from the other labs, as well as the advantages of
RNA-Seq and the novel pathways have been discovered.
The first point we would like to make is that our re-
sults implicate many important genes previously known
to be involved in SCI, such as Socs3 [25], Il17 [26], Tnf
[27], Il6 [26], Il1b [28], CD44 [29], Fgf2 [30], Annexin
[31], Mmp9 [32] and Bax [33]. In addition to these
well-studied genes, many other genes not previously
identified were found to be involved in the response to
SCI. For example, in the acute phase, among the top ten
significantly upregulated genes, we found that colony
Fig. 5 Hierarchical cluster analysis of gene expression in the spinal
cords at different injured stages. Based on similarity of gene expression
patterns, 7632 DEGs were classified into many expression cluster groups.
The blue to red gradation represented gene expressions from down to
up. a: sham control; b: 1 dpi; c: 6 dpi; d: 28 dpi
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stimulating factor 2 receptor beta common subunit
(Csf2rb), perilipin 2 (Plin2), growth arrest and DNA-
damage-inducible protein GADD45 gamma (Gadd45g),
strawberry notch homolog 2 (Sbno2), filamin-C (Flnc),
B cell lymphoma 3 (Bcl3), glioma pathogenesis-related
protein 2 (Glipr2) and tribbles pseudokinase 1 (Trib1)
had not been reported in SCI.
Csf2rb is a common subunit of the GM-CSF receptor,
IL-3 receptor, and IL-5 receptor [34]. GM-CSF has been
shown to inhibit glial scar formation, enhance the integ-
rity of axonal structure and produce a long-term pro-
tective effect after SCI [35]. The roles of IL-3 and IL-5
in SCI are not very clear. However, both of them and
GM-CSF often co-express in TH2 cells, a subset of
Fig. 6 K-means clustering of DEGs. The 7632 DEGs were statistically grouped into 8 subclusters. The trends of distinct significant expression subclusters
were analyzed. A: sham control; B: 1 dpi; C: 6 dpi; D: 28 dpi. (n = 3 in every group)
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CD4+ T cells that are characterized by the production
of IL-4, IL-5, IL-10 and IL-13 [36]. Therefore, in the acute
phase of SCI, upregulation of their co-receptor subunit ex-
pression may be beneficial by exerting anti-inflammatory
effects.
Trib1 has been shown to interact with a number of
proteins, such as MEK-1, MKK4, COP1 and C/EBPalpha
[37, 38]. Satoh et al. demonstrated that Trib1 plays a
critical role in the differentiation of tissue-resident
M2-like macrophages [39]. In our previous study, we
demonstrated that macrophages can be polarized into
M2 subtypes in the early stage of SCI [40]. This is con-
sistent with the high expression of Trib1, which may
play important roles in the differentiation of macro-
phages after SCI.
Gadd45g is involved in DNA repair, cell cycle control,
cellular stress response and apoptosis, among other func-
tions [41]. Sbno2, a novel inflammatory response factor, is
predominantly expressed in astrocytes, as well as in the
choroid plexus and in some microglia, endothelial cells,
and neurons in the CNS [42]. Plin2, also known as adipose
differentiation-related protein, is associated with adipocyte
differentiation [43]. Flnc, also known as filamin-2 or actin-
binding-like protein, is mainly expressed in cardiac and
skeletal muscles and functions by crosslinking actin fila-
ments and anchoring membrane proteins to the actin
cytoskeleton [44]. Bcl3 is a transcriptional co-activator
that is activated through interaction with p50 NF-kappaB
homodimers [45]. Knockout of Bcl3 inhibited fiber at-
rophy and abolished NF-kappa B reporter activity [46].
Glipr2, also known as Golgi-associated plant pathogenesis-
related protein 1, is a member of plant pathogenesis related
proteins group 1 superfamily. It strongly associates with
lipid rafts in the cytosolic leaflet of Golgi membranes [47].
However, little is known about the roles of any of these
genes in SCI.
In the subacute stage, from the ten most significantly
upregulated genes, we found that urokinase-type plas-
minogen activator (Plau), hexokinase-3 (Hk3) and trig-
gering receptor expressed on myeloid cells 2 (Trem2)
had not previously been reported in SCI. Plau is a serine
protease involved in migration and proliferation of some
tumor cells and degradation of the extracellular matrix
[48]. Hk3, an isoform of hexokinases which catalyzes the
first step of glucose metabolism, can increase ATP levels,
reduce oxidant-induced reactive oxygen species, preserve
mitochondrial membrane potential, increase mitochon-
drial biogenesis, and exert protective effects against
oxidative stress [49]. Trem2, a receptor belonging to
the immunoglobulin superfamily, is mainly expressed
on myeloid cells where it stimulates neutrophil- and
monocyte/macrophage-mediated inflammatory responses
[50]. A study by Takahashi et al. reported that expression
of trem2 on microglia increased their scavenging
capability for apoptotic neurons without inflammation
[51]. However, the functions of these genes are poorly
understood in traumatic CNS injuries.
In the chronic phase, from the ten most upregulated
genes, we found that tumor necrosis factor alpha-induced
protein 6 (Tnfaip6), neutrophil cytosol factor 1 (Ncf1), an-
kyrin repeat and suppressor of cytokine signaling box pro-
tein 15 (Asb15), cupredoxins (Cp), tartrate-resistant acid
phosphatase 5 (Acp5) and C-type lectin domain family 4,
member A3 (Clec4a3) had not previously been reported
in SCI.
Ncf1 is a cytosolic subunit of neutrophil NADPH oxi-
dase which can be activated to produce superoxide
anion. Ncf1 and NADPH oxidase 2 complex-derived re-
active oxygen species are important regulators of several
chronic inflammatory disorders, such as multiple scler-
osis, gout, psoriasis and psoriatic arthritis, rheumatoid
arthritis, and lupus [52]. Although there are no reports
of increasing Ncf1 expression in SCI, it may play an im-
portant role in the chronic phase of this pathological
process.
Tnfaip6, a secretory protein induced by tumor necrosis
factor alpha, is involved in extracellular matrix stability
and cell migration, and is important in the protease net-
work associated with inflammation [53]. Asb15, a pro-
tein predominantly expressed in skeletal muscle, has a
role in the regulation of protein turnover and muscle cell
development [54]. Cps are widespread copper-binding
proteins that bind a mononuclear type 1 copper redox site
and are mainly involved in electron transfer reactions,
photosynthesis and respiration [55]. Acp5 is involved in
osteopontin/bone sialoprotein dephosphorylation, which
is essential for bone resorption and osteoclast differenti-
ation [56]. Clec4a3, a member of the C-type lectin-like
domain-containing family which was originally thought to
be important for initiating and shaping immune re-
sponses, has been found to be upregulated in rat spinal
cord following traumatic nerve root injury [57]. However,
whether these genes contribute to the pathological process
of SCI remains unknown.
A second important point regarding our study is that
the genes identified in SCI are involved in many signal-
ing pathways. For example, the TNF [27, 58, 59], Toll-
like receptor [60], NF-kappa B [61], NOD-like receptor
[62] and synapse formation signaling pathways [63] have
been reported to be involved in the pathological process
of SCI [63, 64].
However, there were also some interesting new terms
in SCI found by KEGG pathway analysis. For example,
the ribosome term was significantly enriched in the
whole pathological process. Ribosomes consist of com-
plexes of proteins and RNAs and are complex molecular
machines responsible for protein synthesis in living cells
[65]. Therefore, the upregulation of ribosomal protein
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genes may increase production of corresponding pro-
teins and thus boost ribosome function after SCI. The
boosting function of ribosomal proteins can promote
ribosome biogenesis, which may contribute to cell
growth and proliferation, stress responses and the poten-
tial for repair [66]. However, the mechanisms related to ri-
bosomes in regulating neuronal growth, stress responses
and rehabilitation after SCI remain to be identified. In
addition, some pathways such as retrograde endocannabi-
noid signaling, oxytocin signaling, Rap1 signaling and the
synaptic vesicle cycle were also enriched in the subacute
and chronic phases of SCI. The roles of these pathways in
SCI have never been reported to our knowledge. These
new findings will thus supportfuture research and thera-
peutic development for SCI.
Conclusions
In summary, our study has not only characterized global
changes in gene expression in injured rat spinal cords,
but has also systematically identified the critical genes and
signaling pathways in SCI pathology. Although the genes
associated with damage and repair of spinal cord injury
are still largely unknown, the RNA-Seq analysis presented
in this study will expand our understanding of the com-
plex molecular mechanisms involved and provide a
foundation for future studies of tissue damage and re-
pair after SCI.
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